Entinostat-Bortezomib Hybrids against Multiple Myeloma

Although proteasome inhibitors have emerged as the therapeutic backbone of multiple myeloma treatment, patients often relapse and become drug refractory. The combination between proteasome and histone deacetylase inhibitors has shown to be more efficient compared to monotherapy by enhancing the anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferro, Angelica, Graikioti, Dafni, Gezer, Emre, Athanassopoulos, Constantinos M., Cuendet, Muriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9920246/
https://www.ncbi.nlm.nih.gov/pubmed/36771118
http://dx.doi.org/10.3390/molecules28031456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9920246/
https://www.ncbi.nlm.nih.gov/pubmed/36771118
http://dx.doi.org/10.3390/molecules28031456

Ejemplares similares